Women seemed to be born with a shopping gene. When two women went shopping together, savage was the only word for it.
Even a quiet girl like Wang Zhenzhen was no exception. Before long, Jiang Hao's hands were laden with large and small bags.
In the mall's rest area, a pile of shopping bags sat beside Jiang Hao. The two women had left him there to watch them while they continued their shopping spree.
There were magazines on a nearby rack for customers to read. Jiang Hao glanced over them and spotted a financial magazine with Yamamoto Ryuichi on the cover, so he casually picked it up and flipped through it.
One lengthy article covered the Yamamoto Group, including its various industries. Yamamoto Ryuichi had become a legend of Japan's economy, and Jiang Hao had already learned all that while gathering information earlier.
The report then focused on Yamamoto Pharmaceuticals, a pharmaceutical research company under the Yamamoto Group.
Yamamoto Pharmaceuticals was a publicly traded company. In recent years, it had partnered with Professor Akiyama, a Nobel Prize winner in Physiology or Medicine, and announced a new Immune Body therapy for fighting cancer cells. It had now entered clinical trials.
The drug worked by exploiting the self-protection mechanisms of viral and bacterial pathogens to attack and kill cancer cells.
Once this invention was released, it would work against all cancers, including the world's most common types: lung cancer, stomach cancer, breast cancer, rectal cancer, and more.
As soon as the news came out, Yamamoto Pharmaceuticals' stock had soared. It had multiplied several times over in just more than a year, earning countless investors a fortune. It now stood at 4,552 Japanese Yen per share, a true blue-chip stock.
The report also said that once the drug was fully developed and officially